Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
Link opens in a new tab
English
Deutsch
Search content at Technical University of Munich
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
The FLAMSA concept—past and future
Hans Jochem Kolb
, Christoph Schmid
Helmholtz Zentrum München German Research Center for Environmental Health
Kolb Consulting UG
Universitätsklinikum Augsburg
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The FLAMSA concept—past and future'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fludarabine
100%
Amsacrine
100%
Cytosine Arabinoside
100%
Leukemia
50%
Transplantation
50%
Antileukemic Activity
50%
Immune Cells
25%
Molecular Changes
25%
Elderly Patients
25%
Frail Elderly
25%
Strategies for Improvement
25%
Adoptive Immunotherapy
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
Allogeneic Transplantation
25%
Restitution
25%
Donor Lymphocyte Infusion
25%
Allogeneic
25%
Induction Therapy
25%
New Agents
25%
Remission Induction
25%
Reduced Intensity
25%
High-risk Disease
25%
Sequential Therapy
25%
Refractoriness
25%
Reactive Agent
25%
Anti-leukemia
25%
Medicine and Dentistry
Cytarabine
100%
Fludarabine
100%
Amsacrine
100%
Leukemia
75%
Conditioning
50%
Immunosuppressive Drug
50%
Immunocompetent Cell
25%
Adoptive Immunotherapy
25%
Allograft
25%
Allogeneic Stem Cell Transplantation
25%
Lymphocyte Transfusion
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Amsacrine
100%
Cytarabine
100%
Fludarabine
100%
Leukemia
75%
Immunosuppressive Agent
50%
Molecular Target
25%
Remission
25%
Immunotherapy
25%
Diseases
25%